502 related articles for article (PubMed ID: 23563101)
1. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
[TBL] [Abstract][Full Text] [Related]
2. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques.
Genina N; Fors D; Vakili H; Ihalainen P; Pohjala L; Ehlers H; Kassamakov I; Haeggström E; Vuorela P; Peltonen J; Sandler N
Eur J Pharm Sci; 2012 Oct; 47(3):615-23. PubMed ID: 22902482
[TBL] [Abstract][Full Text] [Related]
3. Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing.
Genina N; Fors D; Palo M; Peltonen J; Sandler N
Int J Pharm; 2013 Sep; 453(2):488-97. PubMed ID: 23769992
[TBL] [Abstract][Full Text] [Related]
4. QR encoded smart oral dosage forms by inkjet printing.
Edinger M; Bar-Shalom D; Sandler N; Rantanen J; Genina N
Int J Pharm; 2018 Jan; 536(1):138-145. PubMed ID: 29183858
[TBL] [Abstract][Full Text] [Related]
5. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
6. Edible solid foams as porous substrates for inkjet-printable pharmaceuticals.
Iftimi LD; Edinger M; Bar-Shalom D; Rantanen J; Genina N
Eur J Pharm Biopharm; 2019 Mar; 136():38-47. PubMed ID: 30630061
[TBL] [Abstract][Full Text] [Related]
7. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
[TBL] [Abstract][Full Text] [Related]
8. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
Sandler N; Määttänen A; Ihalainen P; Kronberg L; Meierjohann A; Viitala T; Peltonen J
J Pharm Sci; 2011 Aug; 100(8):3386-3395. PubMed ID: 21360709
[TBL] [Abstract][Full Text] [Related]
9. Improvement of dissolution rate of indomethacin by inkjet printing.
Wickström H; Palo M; Rijckaert K; Kolakovic R; Nyman JO; Määttänen A; Ihalainen P; Peltonen J; Genina N; de Beer T; Löbmann K; Rades T; Sandler N
Eur J Pharm Sci; 2015 Jul; 75():91-100. PubMed ID: 25817804
[TBL] [Abstract][Full Text] [Related]
10. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
11. Development of 3D Printed Multi-Layered Orodispersible Films with Porous Structure Applicable as a Substrate for Inkjet Printing.
Elbl J; Veselý M; Blaháčková D; Ondruš J; Kulich P; Mašková E; Mašek J; Gajdziok J
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840036
[TBL] [Abstract][Full Text] [Related]
12. Personalisation of warfarin therapy using thermal ink-jet printing.
Vuddanda PR; Alomari M; Dodoo CC; Trenfield SJ; Velaga S; Basit AW; Gaisford S
Eur J Pharm Sci; 2018 May; 117():80-87. PubMed ID: 29414676
[TBL] [Abstract][Full Text] [Related]
13. Colorimetry as Quality Control Tool for Individual Inkjet-Printed Pediatric Formulations.
Wickström H; Nyman JO; Indola M; Sundelin H; Kronberg L; Preis M; Rantanen J; Sandler N
AAPS PharmSciTech; 2017 Feb; 18(2):293-302. PubMed ID: 27738876
[TBL] [Abstract][Full Text] [Related]
14. Drop-on-demand printing of personalised orodispersible films fabricated by precision micro-dispensing.
Tam CH; Alexander M; Belton P; Qi S
Int J Pharm; 2021 Dec; 610():121279. PubMed ID: 34774697
[TBL] [Abstract][Full Text] [Related]
15. Development of Oromucosal Dosage Forms by Combining Electrospinning and Inkjet Printing.
Palo M; Kogermann K; Laidmäe I; Meos A; Preis M; Heinämäki J; Sandler N
Mol Pharm; 2017 Mar; 14(3):808-820. PubMed ID: 28195483
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Inkjet-Printed Pharmaceuticals on Porous Substrates Using Raman Spectroscopy and Near-Infrared Spectroscopy.
Edinger M; Iftimi LD; Markl D; Al-Sharabi M; Bar-Shalom D; Rantanen J; Genina N
AAPS PharmSciTech; 2019 Jun; 20(5):207. PubMed ID: 31161397
[TBL] [Abstract][Full Text] [Related]
17. Application of a colorimetric technique in quality control for printed pediatric orodispersible drug delivery systems containing propranolol hydrochloride.
Vakili H; Nyman JO; Genina N; Preis M; Sandler N
Int J Pharm; 2016 Sep; 511(1):606-618. PubMed ID: 27444550
[TBL] [Abstract][Full Text] [Related]
18. An Investigation into Mechanical Properties and Printability of Potential Substrates for Inkjet Printing of Orodispersible Films.
Turković E; Vasiljević I; Drašković M; Obradović N; Vasiljević D; Parojčić J
Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33808374
[TBL] [Abstract][Full Text] [Related]
19. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder.
Infanger S; Haemmerli A; Iliev S; Baier A; Stoyanov E; Quodbach J
Int J Pharm; 2019 Jan; 555():198-206. PubMed ID: 30458260
[TBL] [Abstract][Full Text] [Related]
20. Hyperspectral imaging in quality control of inkjet printed personalised dosage forms.
Vakili H; Kolakovic R; Genina N; Marmion M; Salo H; Ihalainen P; Peltonen J; Sandler N
Int J Pharm; 2015 Apr; 483(1-2):244-9. PubMed ID: 25527212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
